|
WO2020009714A1
|
|
In-Vitro Induction of Adult Stem Cell Expansion and Derivation
|
|
US2019085335A1
|
|
In-vitro induction of adult stem cell expansion and derivation
|
|
CN109563510A
|
|
MIR-302 presoma is used to be used to treat the composition and method of Human Lung Cancer as anticancer drug
|
|
US2017175118A1
|
|
Composition and method of using miR-302 precursors as anti-cancer drugs for treating human lung cancer
|
|
TW201611829A
|
|
Use of glycylated sugar and glycylated sugar alcohol in manufacturing medications
|
|
US2015209377A1
|
|
Use of monosaccharide-like glycylated sugar alcohol compositions for designing and developing anti-diabetic drugs
|
|
TW201009074A
|
|
Generation of tumor-free embryonic stem-like pluripotent cells using inducible recombinant rna agents
|
|
TW201402812A
|
|
Method of inhibiting targeted cell through gene silencing effect by using recombinant nucleic acid composition
|
|
TW201009073A
|
|
Generation of human embryonic stem-like cells using intronic rna
|
|
AU2003304144A8
|
|
Intracellular production of specific rna molecules by splicing
|
|
AU5785799A
|
|
Method for knocking out gene expression by covalently binding antisense probes
|
|
WO0113959A1
|
|
Method for knocking out gene expression by covalently binding antisense probes
|
|
WO0075356A1
|
|
Rna polymerase chain reaction
|
